PMV Pharmaceuticals, Inc. — Director's Dealing 2025

Oct 29, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2025-10-27

Reporting Person: Mack David Henry (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-27	Common Stock	M	220643	$1.37	Acquired	451109	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-27	Employee Stock Option (right to buy)	$1.37	M	220643	Disposed	2026-11-16	Common Stock (220643)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	165307	Indirect
Common Stock	453582	Indirect
Common Stock	56978	Indirect

Footnotes

F1: Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust (the "Revocable Trust").

F2: The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

F3: Includes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Revocable Trust.

F4: The shares are held of record by the Revocable Trust.

F5: The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

F6: The shares subject to the option are fully vested and immediately exercisable.